Jay Pruetz MD

Jay Pruetz, MD, is an Associate Director of the Congenital Heart Program at Cedars-Sinai. He graduated Cum Laude from the University of California, Los Angeles (UCLA) with a Bachelor of Science in microbiology and molecular genetics in 1996, and graduated from Tufts University School of Medicine as Alpha Omega Alpha in 2001. He completed his pediatric internship and residency at Cedars Sinai Medical Center in 2004 and pediatric cardiology fellowship at CHLA in 2008. Dr. Pruetz was board-certified in Pediatrics in 2004 and has remained subspecialty board-certified in Pediatric Cardiology since 2008.

Dr. Pruetz is actively involved in the prenatal detection and perinatal management of fetuses with congenital heart disease. He cares for these infants long after they are born, both during their inpatient stay in the hospital and in the outpatient clinic. He is now associate director of the Congenital Heart Program (CHP) at Cedars-Sinai and a representative of the Smidt Heart Institute. His research interests include the study of outcomes for fetuses with critical heart lesions and the development of new strategies to improve prenatal and postnatal management.

Dr. Pruetz also has extensive experience in the field of fetal intervention, having published multiple studies on Twin-Twin Transfusion Syndrome, fetal aortic valvuloplasty, and congenital heart block. His unique expertise, paired with the strength of the CSMC obstetrics/perinatal program, will hopefully lead to the development of new and exciting fetal therapies and interventions to treat some of our most complex fetal patients.